A more intense hyperphosphorylation (activation) of AKT and mTOR has been reported in grade-III and -IV gliomas than in low-grade gliomas [119] as related with a poorer prognosis in glioblastoma patients [120]. This evidence concerns the gene AKT1 and central nervous system cancer.